BackCRISPR Therapeutics AG Overview
CRISPR Therapeutics AG

CRISPR Therapeutics AG Target Price

Analysts' 12-month price predictions for CRSP.

Get informed when a big investor buys or sells

+ Follow

Share Price

$60.08

Average Target Price

$68.0013.2% upside

4 analysts in the last 4 months

High: $80 | Low: $56

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-12UBS$8033.2% upsideOpen
2026-06-11Morgan StanleyMaxwell Skor$600.1% downsideOpen
2026-05-13Bernstein$566.8% downsideOpen
2026-05-11Evercore ISI$7626.5% upsideOpen
2026-02-17Morgan Stanley$3345.1% downsideOpen
2026-02-14Chardan CapitalGeulah Livshits$7626.5% upsideOpen
2026-02-13Needham$8236.5% upsideOpen
2026-02-13Evercore ISI$7423.2% upsideOpen
2025-11-26Chardan Capital$7423.2% upsideOpen
2025-11-11RBC CapitalLuca Issi$5016.8% downsideOpen
2025-10-13Wells FargoYanan Zhu$7524.8% upsideOpen
2025-02-03H.C. WainwrightMitchell Kapoor$658.2% upsideOpen
2024-11-06OppenheimerJay Olson$9558.1% upsideOpen
2024-11-05Leerink PartnersRick Bienkowski$6711.5% upsideOpen
2024-08-12Truist FinancialJoon Lee$10066.4% upsideOpen
2024-08-06NeedhamGil Blum$8439.8% upsideOpen
2024-08-06Stifel NicolausBenjamin Burnett$591.8% downsideOpen
2024-08-06RBC CapitalLuca Issi$600.1% downsideOpen
2024-05-09Robert W. BairdJack Allen$5213.4% downsideOpen
2022-11-23Citigroup$634.9% upsideOpen
2022-08-09Chardan CapitalGeulah Livshits$79.332% upsideOpen
2022-06-17BMO CapitalKostas Biliouris$9863.1% upsideOpen
2022-04-28Credit Suisse$7829.8% upsideOpen
2022-02-16NeedhamGil Blum$170183% upsideOpen
2022-02-15Leerink PartnersRick Bienkowski$12099.7% upsideOpen
2022-01-07Wells FargoYanan Zhu$10574.8% upsideOpen
2021-11-04OppenheimerJay Olson$172186.3% upsideOpen
2021-10-12Piper SandlerEdward Tenthoff$180199.6% upsideOpen
2021-08-16Canaccord GenuityArlinda Lee$160166.3% upsideOpen
2021-06-11Roth CapitalAnthony Butler$171184.6% upsideOpen
2021-04-21JefferiesMaury Raycroft$172186.3% upsideOpen